NASDAQ:CXRX (CXRX) (CXRX) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CXRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.19▼$0.2150-Day Range$0.19▼$0.1952-Week Range$0.19▼$1.80Volume648,890 shsAverage Volume267,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CXRX) alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About (CXRX) Stock (NASDAQ:CXRX)Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CXRX Stock News HeadlinesAugust 15, 2023 | bbc.co.ukRangers aim to 'silence the crowd'July 26, 2023 | bbc.com'About getting minutes' - McCall on Rotherham defeatApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.July 26, 2023 | bbc.comHow will you remember Henderson?July 13, 2023 | bbc.comFranklin smashes records to win double goldJuly 13, 2023 | bbc.comSpoony scoops in £160,000 from World CupJuly 11, 2023 | bbc.co.ukFM backs Gething for not reading pandemic plansJuly 10, 2023 | bbc.comZoo names Penguins after Brighton starsApril 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.June 24, 2023 | msn.comGlobal leaders laud AfDB’s role in new financing pactJune 15, 2023 | msn.comCrocodile Beaten to Death After Killing Young BoyJune 14, 2023 | msn.comHow Extreme Heat Is Changing Summer VacationJune 14, 2023 | msn.comCollin County teen is missing, AMBER Alert activatedFebruary 17, 2023 | msn.comNew Jersey bill would increase auto theft penalties, especially for ringleadersFebruary 17, 2023 | msn.comNBA All-Star 2023: Dunk contest, 3-point contest, skills challenge preview & predictionsFebruary 7, 2023 | msn.comElectric vehicles can now power your home for three daysFebruary 7, 2023 | msn.comThe house and car will merge — and change how we power our livesJanuary 22, 2023 | msn.com15-year-old shot and killed in Milford Mill, say policeDecember 12, 2022 | msn.comSPS Academy of Exploration set to move to new space in 2023, triple in sizeNovember 1, 2022 | msn.comShakira helping ill dad, 91, with physiotherapy in hospitalSee More Headlines Receive CXRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CXRX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2016Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:CXRX CUSIPN/A CIK1642271 Webwww.concordiarx.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Allan Oberman (Age 60)CEO & Director Mr. Francesco Tallarico (Age 35)Chief Legal Officer & Sec. Mr. Adrian A. de Saldanha (Age 57)Exec. Mr. Adeel Ahmad (Age 44)Chief Financial Officer of Concordia International Segment H.R.H. David J. Price (Age 55)Chief Financial Officer Key CompetitorsContext TherapeuticsNASDAQ:CNTXGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPView All Competitors CXRX Stock Analysis - Frequently Asked Questions How were (CXRX)'s earnings last quarter? (CXRX) (NASDAQ:CXRX) released its quarterly earnings data on Friday, August, 12th. The company reported $1.38 earnings per share for the quarter, meeting analysts' consensus estimates of $1.38. The firm earned $231.70 million during the quarter, compared to analysts' expectations of $229.76 million. The firm's revenue for the quarter was up 208.1% compared to the same quarter last year. What other stocks do shareholders of (CXRX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CXRX) investors own include Intact Financial (IFC), Constellation Software (CSU), Concordia International (CXR), Hudbay Minerals (HBM), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), First Quantum Minerals (FM), Lundin Mining (LUN), AbbVie (ABBV) and Teck Resources (TECK). This page (NASDAQ:CXRX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CXRX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
